Metabolic Mechanisms in the Pathogenesis of Osteoarthritis

Journal of Knee Surgery

Volumn 19, Issue 3, 2006, Pages 191-197

  Burnett, Bruce P ^a   Levy, Robert ^a   Cole, Brian J ^b  

^a PRIMUS PHARMACEUTICALS INC   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONATE 5 LIPOXYGENASE; ARACHIDONIC ACID; CYTOKINE; REACTIVE OXYGEN METABOLITE;

AGING; CUMULATIVE TRAUMA DISORDER; DIET; HUMAN; IMMUNOLOGY; INJURY; JOINT; METABOLISM; MUSCLE WEAKNESS; OBESITY; OSTEOARTHRITIS; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW;

AGING; ARACHIDONATE 5-LIPOXYGENASE; ARACHIDONIC ACID; CUMULATIVE TRAUMA DISORDERS; CYTOKINES; DIET; HUMANS; JOINTS; MUSCLE WEAKNESS; OBESITY; OSTEOARTHRITIS; REACTIVE OXYGEN SPECIES;

EID: 34848871748     PISSN: 15388506     EISSN: 19382480     Source Type: Journal    
DOI: 10.1055/s-0030-1248105     Document Type: Review

References (93)

1. Abramson S.B. Inflammation in osteoarthritis. J Rheumatol Suppl. 2004;31:70-76.
2. Anderson J.J., Felson D.T. Factors associated with osteoarthritis of the knee in the first national Health and Nutrition Examination Survey (HANES I). Evidence for an association with overweight, race, and physical demands of work. Am J Epidemiol. 1988;128:179-189.
3. Aspden R.M., Scheven B.A., Hutchison J.D. Osteoarthritis is a systemic disorder involving stromal cell differentiation and lipid metabolism. Lancet. 2001;357:1118-1120.
4. Attur M.G., Dave M., Akamatsu M., Katoh M., Amin A.R. Osteoarthritis or osteoarthrosis: the definition of inflammation becomes a semantic issue in the genomic era of molecular medicine. Osteoarthritis Cartilage. 2002;10:1-4.
5. Ayral X., Dougados M., Listrat V., Bonvarlet J.P., Simonnet J., Amor B. Arthroscopic evaluation of chondropathy in osteoarthritis of the knee. J Rheumatol. 1996;23:698-706.
6. Basu S., Whiteman M., Mattey D.L., Halliwell B. Raised levels of F(2)-isoprostanes and prostaglandin F(2alpha) in different rheumatic diseases. Ann Rheum Dis. 2001;60:627-631.
7. Blumenfeld I., Levine E. The role of transforming growth factor (TGF)-beta, insulin-like growth factor (IGF)-1, and interleukin (IL)-1 in osteoarthritis and aging of joints. Exp Gerontol. 1999;34:821-829.
8. Bonizzi G., Piette J., Merville M.P., Bours V. Cell type-specific role for reactive oxygen species in nuclear factor-kappaB activation by interleukin-1. Biochem Pharmacol. 2000;59:7-11.
9. Brandi M.L., Gennari L., Cerinic M.M., et al. Genetic markers of osteoarticular disorders: facts and hopes. Arthritis Res. 2001;3:270-280.
10. Brash A.R. Arachidonic acid as a bioactive molecule. J Clin Invest. 2001;107:1339-1345.
11. Brigelius-Flohe R., Banning A., Kny M., Bol G.F. Redox events in interleukin-1 signaling. Arch Biochem Biophys. 2004;423:66-73.
12. Buckwalter J.A., Saltzman C., Brown T. The impact of osteoarthritis: implications for research. Clin Orthop. 2004;427(Suppl):S6-S15.
13. Dandona P., Aljada A., Bandyopadhyay A. Inflammation: the link between insulin resistance, obesity and diabetes. Trends Immunol. 2004;25:4-7.
14. Dannhardt G., Kiefer W. Cyclooxygenase inhibitors-current status and future prospects. Eur J Med Chem. 2001;36:109-126.
15. Deschner J., Hofman C.R., Piesco N.P., Argarwal S. Signal transduction by mechanical strain in chondrocytes. Curr Opin Clin Nutr Metab Care. 2003;6:289-293.
16. Dieppe P.A., Cushnaghan J., Shepstone L. The Bristol ‘0A500’ study: progression of osteoarthritis (OA) over 3 years and the relationship between clinical and radiographic changes at the knee joint. Osteoarthritis Cartilage. 1997;5:87-97.
17. Dijkgraaf L.C., de Bont L.G., Boering G., Liem R.S. Thestructure, biochemistry, and metabolism of osteoarthritic cartilage: a review of the literature. J Oral Maxillofac Surg. 1995;53:1182-1192.
18. Docherty A.J., Murphy G. The tissue metalloproteinase family and the inhibitor TIMP: a study using cDNAs and recombinant proteins. Ann Rheum Dis. 1990;49:469-479.
19. Dougados M., Gueguen A., Nguyen M., et al. Longitudinal radiologic evaluation of osteoarthritis of the knee. J Rheumatol. 1992;19:378-384.
20. Dougados M., Gueguen A., Nguyen M., et al. Radiological progression of hip osteoarthritis: definition, risk factors and correlations with clinical status. Ann Rheum Dis. 1996;55:356-362.
21. Esterbauer H., Schaur R.J., Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde, and related aldehydes. Free Radic Biol Med. 1991;11:81-128.
22. Favus M.J., Utset T.O., Lee C. Nutritional support and management of musculoskeletal diseases. In: Bronner F, ed. Nutritional Aspects of Clinical Management of Chronic Disorders and Diseases. Boca Raton, Fla: CRC Press; 2003:129-154.
23. Felson D.T. Risk factors for osteoarthritis: understanding joint vulnerability. Clin Orthop. 2004;427(Suppl):S16-S21.
24. Felson D.T. Weight and osteoarthritis. J Rheumatol. 1995;43:7-9.
25. Felson D.T., Lawrence R.C., Dieppe P.A., et al. Osteoarthritis: new insights, part 1: the disease and its risk factors. Ann Intern Med. 2000;133:635-646.
26. Felson D.T., Lawrence R.C., Hochberg M.C., et al. Osteoarthritis: new insights, part 2: treatment approaches. Ann Intern Med. 2000;133:726-737.
27. Felson D.T., Zhang Y. An update on the epidemiology of knee and hip osteoarthritis with a view to prevention. Arthritis Rheum. 1998;41:1343-1355.
28. Felson D.T., Zhang Y., Anthony J.M., Naimark A., Anderson J.J. Weight loss reduces the risk for symptomatic knee osteoarthritis in women. The Framingham Study. Ann Intern Med. 1992;116:535-539.
29. Felson D.T., Zhang Y., Hannan M.T., et al. Risk factors for incident radiographic knee osteoarthritis in the elderly: the Framingham Study. Arthritis Rheum. 1997;40:728-733.
30. Fernandes J.C., Martel-Pelletier J., Pelletier J.P. The role of cytokines in osteoarthritis pathophysiology. Biorheology. 2002;39:237-246.
31. Goldring S.R., Goldring M.B. The role of cytokines in cartilage matrix degeneration in osteoarthritis. Clin Orthop. 2004;427(Suppl):S27-S36.
32. Greenwald R.A., Moy W.W. Inhibition of collagen gelation by action of the superoxide radical. Arthritis Rheum. 1979;22:251-259.
33. Haklar U., Yuksel M., Velioglu A., Turkmen M., Haklar G., Yalcin A.S. Oxygen radicals and nitric oxide levels in chondral or meniscal lesions or both. Clin Orthop. 2002;403:135-142.
34. Hardy M.M., Seibert K., Manning P.T., et al. Cyclooxygen-ase 2-dependent prostaglandin E2 modulates cartilage proteoglycan degradation in human osteoarthritis explants. Arthritis Rheum. 2002;46:1789-1803.
35. Hart D.J., Doyle D.V., Spector T.D. Association between metabolic factors and knee osteoarthritis in women: the Chingford Study. J Rheumatol. 1995;22:1118-1123.
36. Hart D.J., Doyle D.V., Spector T.D. Incidence and risk factors for radiographic knee osteoarthritis in middle-aged women: the Chingford study. Arthritis Rheum. 1999;42:17-24.
37. Hart D.J., Spector T.D. The relationship of obesity, fat distri-bution and osteoarthritis in women in the general population: the Clingford Study. J Rheumatol. 1993;20:331-335.
38. Henrotin Y., Deby-Dupont G., Deby C., Franchimont P., Emerit I. Active oxygen species, articular inflammation, and cartilage damage. EXS. 1992;62:308-322.
39. Henrotin Y.E., Bruckner P., Pujol J.P. The role of reactive oxygen species in homeostasis and degradation of cartilage. Osteoarthritis Cartilage. 2003;11:747-755.
40. Herschman H.R. Regulation of prostaglandin synthase-1 and prostaglandin synthase-2. Cancer Metastasis Rev. 1994;134:241-256.
41. Herzog W., Longino D., Clark A. The role of muscles in joint adaptation and degeneration. Langenbecks Arch Surg. 2003;388:305-315.
42. Horton W.E. Jr, Lethbridge-Cejku M., Hochberg M.C., et al. An association between an aggrecan polymorphic allele and bilateral hand osteoarthritis in elderly white men: data from the Baltimore Longitudinal Study of Aging (BLSA). Osteoarthritis Cartilage. 1998;6:245-251.
43. Hunter D.J., Hart D., Snieder H., Bettica P., Swaminathan R., Spector T.D. Evidence of altered bone turnover, vitamin D and calcium regulation with knee osteoarthritis in female twins. Rheumatology (Oxford). 2003;42:1311-1316.
44. Jessop J.J., Hoffman T. Production and release of IL-1 beta by human peripheral blood monocytes in response to diverse stimuli: possible role of “microdamage” to account for unregulated release. Lymphokine Cytokine Res. 1993;12:51-58.
45. Jimenez S.A., Williams C.J., Karasick D. Hereditary osteoarthritis. In: Brandt KD, Doherty M, Lohmander LS, eds. Osteoarthritis. Oxford, United Kingdom: Oxford University Press; 1988:31-49.
46. Keen R.W., Hart D.J., Lanchbury J.S., Spector T.D. Association of early osteoarthritis of the knee with a Taq I polymorphism of the vitamin D receptor gene. Arthritis Rheum. 1997;40:1444-1449.
47. Lajeunesse D., Reboul P. Subchondral bone in osteoarthri-tis: a biologic link with articular cartilage leading to abnormal remodeling. Curr Opin Rheumatol. 2003;15:628-633.
48. Leveille S.G. Musculoskeletal aging. Curr Opin Rheumatol. 2004;16:114-118.
49. Lippiello L. Lipid and cell metabolic changes associated with essential fatty acid enrichment of articular chondro-cytes. Proc Soc Exp Biol Med. 1990;195:282-287.
50. Lippiello L., Walsh T., Fienhold M. The association of lipid abnormalities with tissue pathology in human osteoar-thritic articular cartilage. Metabolism. 1991;40:571-576.
51. Loughlin J., Sinsheimer J.S., Mustafa Z., et al. Association of the vitamin D receptor gene, the type I collagen gene COL1A1, and the estrogen receptor gene in idiopathic os-teoarthritis. J Rheumatol. 2000;27:779-784.
52. Lozada C.J., Altman R.D. Management of osteoarthritis. In: Koopman WJ, ed. Arthritis and Related Conditions. Philadelphia, Pa: Lippincott, Williams & Wilkins; 2001:2246.
53. Maetzel A., Makela M., Hawker G., Bombardier C. Osteo-arthritis of the hip and knee and mechanical occupational exposure-a systematic overview of the evidence. J Rheumatol. 1997;24:1599-1607.
54. Malemud C.J. Cytokines as therapeutic targets for osteoarthritis. BioDrugs. 2004;18:23-35.
55. Martel-Pelletier J., Alaaeddine N., Pelletier J.P. Cytokines and their role in the pathophysiology of osteoarthritis. Front Biosci. 1999;4:694-703.
56. Martel-Pelletier J., Lajeunesse D., Reboul P., Pelletier J.P. Therapeutic role of dual inhibitors of 5-LOX and COX, selective and non-selective non-steroidal antiinflammatory drugs. Ann Rheum Dis. 2003;62:501-509.
57. McAlindon T., Felson D.T. Nutrition: risk of osteoarthritis. Ann Rheum Dis. 1997;56:397-402.
58. McAlindon T., Zhang Y., Hanna M., et al. Are risk factors for patellofemoral and tibiofemoral knee osteoarthritis different? J Rheumatol. 1996;23:332-337.
59. McAlindon T.E., Felson D.T., Zhang Y., et al. Relation of dietary intake and serum levels of vitamin D to progression of osteoarthritis of the knee among participants in the Framingham study. Ann Intern Med. 1996;125:353-359.
60. McAlindon T.E., Jacques P., Zhang Y., et al. Do antioxi-dant micronutrients protect against the development and progression of knee osteoarthritis? Arthritis Rheum. 1996;39:648-656.
61. McCord J.M. Free radicals and inflammation: protection of synovial fluid by superoxide dismutase. Science. 1974;185:529-531.
62. Melchiorri C., Meliconi R., Frizziero L., et al. Enhanced and coordinated in vivo expression of inflammatory cytokines and nitric oxide synthase by chondrocytes from patients with osteoarthritis. Arthritis Rheum. 1998;41:2165-2174.
63. Meulenbelt I., Bijkerk C., Miedema H.S., et al. A genetic association study of the IGF-I gene and radiological osteoarthritis in a population-based cohort study (the Rotterdam study). Ann Rheum Dis. 1998;57:371-374.
64. Middleton E. Jr, Kandaswami C., Theoharides T.C. The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. Pharmacol Rev. 2000;52:673-751.
65. Miquel J. Nutrition and ageing. Public Health Nutr. 2001;4:1385-1388.
66. Nakao S., Ogata, Y., Shimizu-Sasaki E., Yamazaki M., Furuyama S., Sugiya H. Activation of NFkappaB is necessary for IL-1beta-induced cyclooxygenase-2 (COX-2) expression in human gingival fibroblasts. Mol Cell Biochem. 2000;209:113-118.
67. O’Reilly S.C., Jones A., Muir K.R., Doherty M. Quadriceps weakness in knee osteoarthritis: the effect on pain and disability. Ann Rheum Dis. 1998;57:588-594.
68. Peat G., McCarney R., Croft P. Knee pain and osteoarthritis in older adults: a review of community burden and current use of primary health care. Ann Rheum Dis. 2001;60:91-97.
69. Plumb M.S., Aspden R.M. High levels of fat and (n-6) fatty acids in cancellous bone in osteoarthritis. Lipids in Health and Disease. 2004;3:12.
70. Rathakrishnan C., Tiku K., Raghavan A., Tiku M.L. Release of oxygen radicals by articular chondrocytes: a study of lu-minol-dependent chemoluminescence and hydrogen peroxide secretion. J Bone Miner Res. 1992;7:1139-1148.
71. Roberts L.J., Morrow J.D. The generation and actions of isoprostanes. Biochim Biophys Acta. 1997;1345:121-135.
72. Roos E.M. Joint injury causes knee osteoarthritis in young adults. Curr Opin Rheumatol. 2005;17:195-200.
73. Sowers M. Epidemiology of risk factors for osteoarthritis: systemic factors. Curr Opin Rheumatol. 2001;13:447-451.
74. Spector T.D., Campion G.D. Generalised osteoarthritis: a hormonally mediated disease. Ann Rheum Dis. 1989;48:523-527.
75. Spector T.D., Dacre J.E., Harris P.A., Huskisson E.C. Radiological progression of osteoarthritis: an 11 year follow up study of the knee. Ann Rheum Dis. 1992;51:1107-1110.
76. Steiner D.R., Gonzalez N.C., Wood J.G. Leukotriene B(4) promotes reactive oxidant generation and leukocyte adherence during acute hypoxia. JAppl Physiol. 2001;91:1160-1167.
77. Stockwell R.A. Cartilage failure in osteoarthritis: relevance of normal structure and function. A review. Clin Anat. 1991;4:161-191.
78. Teixeira S. Bioflavonoids: proanthocyanidins and quer-citin and their potential roles in treating musculoskeletal conditions. J Orthop Sports Phys Ther. 2002;32:357-363.
79. Tiku M.L., Gupta S., Deshmukh D.R. Aggrecan degradation in chondrocytes is mediated by reactive oxygen species and protected by antioxidants. Free Radic Res. 1999;30:395-405.
80. Tiku M.L., Yan Y.P., Chen K.Y. Hydroxyl radical formation in chondrocytes and cartilage as detected by electron paramagnetic resonance spectroscopy using spin trapping reagents. Free Radic Res. 1998;29:177-187.
81. Uitterlinden A.G., Burger H., Huang Q., et al. Vitamin D receptor genotype is associated with radiographic osteo-arthritis at the knee. J Clin Invest. 1997;100:259-263.
82. Ushiyama T., Ueyama H., Inoue K., Nishioka J., Ohkubo I., Hukuda S. Estrogen receptor gene polymorphism and generalized osteoarthritis. J Rheumatol. 1998;25:134-137.
83. Vincenti M.P., Brinckerhoff C.E. Transcriptional regulation of collagenase (MMP-1, MMP-13) genes in arthritis: integration of complex signaling pathways for the recruitment of gene-specific transcription factors. Arthritis Res. 2002;4:157-164.
84. Watkins B.A., Xu H., Turek J.J. Linoleate impairs collagen synthesis in primary cultures of avian chondrocytes. Proc Soc Exp Biol Med. 1996;212:153-159.
85. Westacott C.I., Urban J.P., Goldring M.B., Elson C.J. The ef-fects of pressure on chondrocyte tumour necrosis factor receptor expression. Biorheology. 2002;39:125-132.
86. White-O’Connor B., Sobal J., Muncie H.L. Dietary habits, weight history and vitamin supplement use in elderly os-teoarthritis patients. J Am Diet Assoc. 1989;89:378-382.
87. Williams C.J., Jimenez S.A. Heritable diseases of cartilage caused by mutations in collagen genes. J Rheumatol. 1995;43(Suppl):28-33.
88. Woo C.H., Eom Y.W., Yoo M.H., et al. Tumor necrosis factor-alpha generates reactive oxygen species via a cyto-solic phospholipase A2-linked cascade. J Biol Chem. 2000;275:32357-32362.
89. Woolf A.D., Pfleger B. Burden of major musculoskeletal conditions. Bull World Health Organ. 2003;81:646-656.
90. Wright J.M. The double-edged sword of COX-2 selective NSAIDs. CMAJ. 2002;167:1131-1137.
91. Yamada Y., Okuizumi H., Miyauchi A., Takagi Y., Ikeda K., Harada A. Association of transforming growth factor beta 1 genotype with spinal osteophytosis in Japanese women. Arthritis Rheum. 2000;43:452-460.
92. Yan X., Wu Xiao C., Sun M., Tsang B.K., Gibb W. Nuclear factor kappa B activation and regulation of cyclooxygenase type-2 expression in human amnion mesenchymal cells by interleukin-1beta. Biol Reprod. 2002;66:1667-1671.
93. Zhou B.F., Stamler J., Dennis B., et al. Nutrient intakes of middle-aged men and women in China, Japan, United Kingdom, and United States in the late 1990s: the INTER-MAP study. J Hum Hypertens. 2003;17:623-630.